Dream phenomena induced by chronic levodopa therapy
The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
Twenty-seven of eighty-eight (30.7%) Parkinsonian patients on chronic levodopa or levodopa/carbidopa therapy developed drug related dream phenomena. The patients reported three separate types of new dreams which we have classified as vivid dreams, night terrors and nightmares. These dreams are correlated to the duration of levodopa therapy although the mechanism of their production is unclear.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Broughton, R. J. (1968) · Science · doi:10.1126/science.159.3819.1070 · Cited by 637
Dream reports from different stages of sleep
Foulkes, W. D. (1962) · The Journal of Abnormal and Social Psychology · doi:10.1037/h0040431 · Cited by 563
(1973) · Elsevier eBooks · doi:10.1016/b978-0-120-78150-8.x5001-4 · Cited by 539
L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.
Barbeau, A. (1969) · PubMed · Cited by 410
Levodopa-induced psychosis: a kindling phenomenon
(1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.6.669 · Cited by 326
Self-citationMental activity at sleep onset.
Foulkes, D., & Vogel, G. (1965) · Journal of Abnormal Psychology · doi:10.1037/h0022217 · Cited by 318
Sleep Disorders: Recent Findings in the Diagnosis and Treatment of Disturbed Sleep
Kales, A., & Kales, J. D. (1974) · New England Journal of Medicine · doi:10.1056/nejm197402282900905 · Cited by 178
Kales, A., Ansel, R. D., Markham, C. H., Scharf, M. B., & Tan, T.-L. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971122part2397 · Cited by 169
Psychosis and Other Psychiatric Manifestations of Levodopa Therapy
Celesia, G. G., & Barr, A. N. (1970) · Archives of Neurology · doi:10.1001/archneur.1970.00480270003001 · Cited by 167
The nature of the narcoleptic sleep attack
Dement, W., Rechtschaffen, A., & Gulevich, G. (1966) · Neurology · doi:10.1212/wnl.16.1.18 · Cited by 163
Research works printed but not linked: 7
- Barbeau, A. L-dopa therapy in Parkinsons disease a critical review of Hines years experience. Can. Med. Assoc. J.101, 59–68 (1969).
- Goodwin, F. K. Behavioral effects of levodopa in man. Semin. Psychiatry3, 477–492 (1971).
- Kales, A., Scharf, M., Tan, T. L. Sleep laboratory and clinical studies of the effects of Tofranil, Valium, and placebo on sleep stages and enuresis. Psychophysiology7, 350–352 (1970).
- Klawans, H. L., Garvin, J. S. Treatment of Parkinsonian with L-dopa. Dis. Nerv. Syst.30, 733–746 (1969).
- Post, R. M., Gillin, J. C., Wyatt, R. J., Goodwin, F. K., Snyder, F., Bunney, W. E. REM sleep suppressing effects of intravenous L-dopa given during sleep. Psychophysiology9, 88 (1972).
- Schmidt, H. S., Knopp, W. Sleep in Parkinson's disease: The effect of L-dopa. Psychophysiology9, 88 (1972).
- Spitzer, H., Zarcone, V., Barchas, J., Ryan, R., Smythe, H., Dement, W. Administration of 5-hydroxytryptophan (5-HTP) to a L-dihydroxy-phenylamine (L-dopa) treated patient with Shy-Drager syndrome. Psychophysiology9, 87 (1972).
Cited by
Dreaming and the brain: toward a cognitive neuroscience of conscious states
Hobson, J. A., Pace-Schott, E. F., & Stickgold, R. (2000) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00003976 · Cited by 985
An algorithm (decision tree) for the management of Parkinson’s disease (2001): Treatment Guidelines
Olanow, C. W., Watts, R. L., & Koller, W. C. (2001) · Neurology · doi:10.1212/wnl.56.suppl_5.s1 · Cited by 715
The reinterpretation of dreams: An evolutionary hypothesis of the function of dreaming
Revonsuo, A. (2000) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00004015 · Cited by 676
Sleep disorders and sleep effect in Parkinson's disease
Factor, S. A., McAlarney, T., Sanchez‐Ramos, J. R., & Weiner, W. J. (1990) · Movement Disorders · doi:10.1002/mds.870050404 · Cited by 358
Dopaminergic Control of Sleep–Wake States
Dzirasa, K., Ribeiro, S., Costa, R., Santos, L. M., Lin, S.-C., Grosmark, A., Sotnikova, T. D., Gainetdinov, R. R., Caron, M. G., & Nicolelis, M. A. L. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1767-06.2006 · Cited by 319
Sleep disorders in Parkinson's disease
Kumar, S., Bhatia, M., & Behari, M. (2002) · Movement Disorders · doi:10.1002/mds.10167 · Cited by 258
Pacchetti, C., Manni, R., Zangaglia, R., Mancini, F., Marchioni, E., Tassorelli, C., Terzaghi, M., Ossola, M., Martignoni, E., Moglia, A., et al. (2005) · Movement Disorders · doi:10.1002/mds.20582 · Cited by 243
The roles of the reward system in sleep and dreaming
Perogamvros, L., & Schwartz, S. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.05.010 · Cited by 239
Kunz, D., & Bes, F. (1999) · Movement Disorders · doi:10.1002/1531-8257(199905)14:3<507::aid-mds1021>3.0.co;2-8 · Cited by 236
Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease
van Hilten, J. J., Weggeman, M., van der Velde, E. A., Kerkhof, G. A., van Dijk, J. G., & Roos, R. A. C. (1993) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02257678 · Cited by 205
Garcia-Borreguero, D., Larrosa, O., & Bravo, M. (2003) · Sleep Medicine Reviews · doi:10.1053/smrv.2002.0229 · Cited by 204
Update on the pharmacology of REM sleep behavior disorder
Gagnon, J.-F., Postuma, R. B., & Montplaisir, J. (2006) · Neurology · doi:10.1212/01.wnl.0000233926.47469.73 · Cited by 196
Fall, P.-A., Fredrikson, M., Axelson, O., & Gran�rus, A.-K. (1999) · Movement Disorders · doi:10.1002/1531-8257(199901)14:1<28::aid-mds1007>3.0.co;2-o · Cited by 244
Sleep disturbances in Parkinson's disease
Menza, M., Dobkin, R. D., Marin, H., & Bienfait, K. (2010) · Movement Disorders · doi:10.1002/mds.22788 · Cited by 165
“An increase in dreaming is common in PD, with studies suggesting that about 30% of patients develop vivid dreams on dopaminergic therapies.(29) Because vivid dreams are often a prodrome of daytime hallucinations,(30) one should query patients about this phenomenon.”
BackgroundSiclari, F., Khatami, R., Urbaniok, F., Nobili, L., Mahowald, M. W., Schenck, C. H., Cramer Bornemann, M. A., & Bassetti, C. L. (2010) · Brain · doi:10.1093/brain/awq296 · Cited by 131
Pal, P. K., Thennarasu, K., Fleming, J., Schulzer, M., Brown, T., & Calne, S. M. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2003.11.002 · Cited by 127
“Excessive and vivid dreams, night terrors and nightmares are more common in PD-the prevalence increasing with duration of treatment with dopaminomimetics [46] and these may contribute to SD.”
BackgroundSleep and brain lesions: a critical review of the literature and additional new cases
Autret, A., Lucas, B., Mondon, K., Hommet, C., Corcia, P., Saudeau, D., & de Toffol, B. (2001) · Neurophysiologie Clinique · doi:10.1016/s0987-7053(01)00282-9 · Cited by 119
Visual Hallucinations in PD and Lewy Body Dementias: Old and New Hypotheses
ONOFRJ, M. C., Taylor, J., Monaco, D., Franciotti, R., Anzellotti, F., Bonanni, L., Onofrj, V., & Thomas, A. (2013) · Behavioural Neurology · doi:10.1155/2013/703924 · Cited by 108
Sleep Disorders in Patients with Parkinson??s Disease: Epidemiology and Management
Larsen, J. P., & Tandberg, E. (2001) · CNS Drugs · doi:10.2165/00023210-200115040-00002 · Cited by 102
Dreams and nightmares in healthy adults and in patients with sleep and neurological disorders
Siclari, F., Valli, K., & Arnulf, I. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30275-1 · Cited by 98
Sleep in Neurodegenerative Diseases
Iranzo, Á. (2016) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2015.10.011 · Cited by 105
Prevalence of non motor features in a cohort of Parkinson's disease patients
Khedr, E. M., Elfetoh, N. A., Khalifa, H., Ahmed, M., & Elbeh, K. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2012.07.032 · Cited by 99
Clozapine prevents recurrence of psychosis in Parkinson's disease
Factor, S. A., & Brown, D. L. (1992) · Movement Disorders · doi:10.1002/mds.870070205 · Cited by 90
SLEEP AND DEGENERATIVE NEUROLOGIC DISORDERS
Chokroverty, S. (1996) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70286-3 · Cited by 96
A review of normal sleep and its disturbances in Parkinson’s disease
Pal, P. K., Calne, S. M., Samii, A., & Fleming, J. A. E. (1999) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(99)00011-5 · Cited by 92
Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease
Nomura, T., Inoue, Y., Mitani, H., Kawahara, R., Miyake, M., & Nakashima, K. (2003) · Movement Disorders · doi:10.1002/mds.10439 · Cited by 76
Mota, N. B., Weissheimer, J., Ribeiro, M., de Paiva, M. M. M., Avilla-Souza, J., Simabucuru, G., Chaves, M. F., Cecchi, L., de Oliveira, J. B. C., Cecchi, G., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242903 · Cited by 80
Psychiatric side effects during the treatment of Parkinson’s disease
Klawans, H. L. (1988) · Springer eBooks · doi:10.1007/978-3-7091-8954-2_11 · Cited by 73
Self-citationDopaminergic Therapies for Non-motor Symptoms in Parkinson’s Disease
Schaeffer, E., & Berg, D. (2017) · CNS Drugs · doi:10.1007/s40263-017-0450-z · Cited by 76
“Moreover, night-time hallucinations or vivid dreams, which can be induced by dopaminergic agents [63], can be mistaken for RBD, which can be ruled out by detailed anamnesis or polysomnography.”
Cipolli, C., Ferrara, M., De Gennaro, L., & Plazzi, G. (2017) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.07.005 · Cited by 67
Sleep disorders in the elderly
Shochat, T., Loredo, J. S., & Ancoli‐Israel, S. (2001) · Current Treatment Options in Neurology · doi:10.1007/s11940-001-0021-x · Cited by 69
Experimental research on dreaming: state of the art and neuropsychoanalytic perspectives
Ruby, P. M. (2011) · Frontiers in Psychology · doi:10.3389/fpsyg.2011.00286 · Cited by 63
“Second, as Solms (2000) argued, the amount of dream recall can be modulated by dopamine agonists (Scharf et al., 1978; Nausieda et al., 1982) without concomitant modification of the duration and frequency of REM sleep (Hartmann et al.”
BackgroundTreatment of the Sleep Disorders Associated with Parkinson's Disease
Trotti, L. M., & Bliwise, D. L. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0236-z · Cited by 66
Psychosis in Parkinson’s Disease
Wint, D. P., Okun, M. S., & Fernandez, H. H. (2004) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988704267457 · Cited by 57
“It is well recognized that dopaminergic agonists, such as cocaine and amphetamine, can induce psychotic states(22); conversely, dopamine antagonists such as haloperidol and pimozide are effective antipsychotics.(19) There are experimental suggestions that chronic stimulation may cause persistent sensitization of dopam…”
BackgroundSleeping dreams, waking hallucinations, and the central nervous system.
Mahowald, M. W., Woods, S. R., & Schenck, C. H. (1998) · Dreaming · doi:10.1023/b:drem.0000005899.59224.17 · Cited by 58
VALLI, K., FRAUSCHER, B., GSCHLIESSER, V., WOLF, E., FALKENSTETTER, T., SCHÖNWALD, S. V., EHRMANN, L., ZANGERL, A., MARTI, I., BOESCH, S. M., et al. (2012) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2011.00938.x · Cited by 57
Sleep disorders in Parkinson’s disease: a narrative review of the literature
Raggi, A., Bella, R., Pennisi, G., Neri, W., & Ferri, R. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0002 · Cited by 63
“Sleep terrors, vivid dreams and nightmares are much more common in patients taking medications than in those who are drug-free (Sharf et al., 1978).”
BackgroundCarhart-Harris, R. (2007) · Neuropsychoanalysis · doi:10.1080/15294145.2007.10773557 · Cited by 56
Sleep disturbances in Parkinsonism
Askenasy, J. J. M. (2003) · Journal of Neural Transmission · doi:10.1007/s007020300001 · Cited by 59
“SRH prevalence in PD patients with altered dreams is considered to be 21.8–29.5% (Factor et al., 1990; Sharf et al., 1978).”
BackgroundInfluentialDrug-Induced Sleep Disturbances: Focus on Nonpsychotropic Medications
Novák, M., & Shapiro, C. M. (1997) · Drug Safety · doi:10.2165/00002018-199716020-00005 · Cited by 67
Non-Motor Aspects of Parkinson's Disease
Borek, L. L., Amick, M. M., & Friedman, J. H. (2006) · CNS Spectrums · doi:10.1017/s1092852900013560 · Cited by 62
Nightmares and Other Common Dream Disturbances
Nielsen, T., & Zadra, A. L. (2005) · Elsevier eBooks · doi:10.1016/b0-72-160797-7/50084-7 · Cited by 55
Neuropsychiatry of Parkinson's disease
Kümmer, A., & Teixeira, A. L. (2009) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2009000500033 · Cited by 55
Dopaminergic system and dream recall: an MRI study in Parkinson's disease patients
De Gennaro, L., Lanteri, O., Piras, F., Scarpelli, S., Assogna, F., Ferrara, M., Caltagirone, C., & Spalletta, G. (2016) · Human Brain Mapping · doi:10.1002/hbm.23095 · Cited by 45
“At a first glance, our finding seems inconsistent with some reports of vivid dreams and intensified dreamlike mentation during the course of chronic levodopa treatment [Nausieda et al., 1982; Scharf et al., 1978].”
ResultPsychosis in Parkinson’s disease: ‘between a rock and a hard place’
Henderson, M. J., & Mellers, J. D. C. (2000) · International Review of Psychiatry · doi:10.1080/09540260020002541 · Cited by 43
EEG oscillations during sleep and dream recall: state- or trait-like individual differences?
Scarpelli, S., D’Atri, A., Gorgoni, M., Ferrara, M., & Gennaro, L. D. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.00605 · Cited by 41
Onofrj, M., Thomas, A., & Bonanni, L. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.12.1731 · Cited by 41
Motor Functions and Dysfunctions of Sleep
Hening, W. A., Allen, R. P., Walters, A. S., & Chokroverty, S. (2009) · Elsevier eBooks · doi:10.1016/b978-0-7506-7584-0.00028-8 · Cited by 41
Hallucinations in Parkinson's disease
Korczyn, A. D. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06230-4 · Cited by 42
A laboratory study of sleep and dreaming in a case of Asperger's Syndrome.
Godbout, R., Bergeron, C., Stip, É., & Mottron, L. (1998) · Dreaming · doi:10.1023/b:drem.0000005898.95212.58 · Cited by 42
Bollu, P. C., & Sahota, P. K. (2017) · Europe PMC (PubMed Central) · Cited by 67
Epidemiology and clinical features of sleep disorders in extrapyramidal disease
Brotini, S., & Gigli, G. L. (2004) · Sleep Medicine · doi:10.1016/j.sleep.2003.10.012 · Cited by 36
“[74] Sharf B, Moskovitz C, Lupton MD, Klawans HL.”
BackgroundAuditory Inhibition of Rapid Eye Movements and Dream Recall from REM Sleep
Stuart, K., & Conduit, R. (2009) · SLEEP · doi:10.1093/sleep/32.3.399 · Cited by 39
Yu, C. K.-C. (2001) · Neuropsychoanalysis · doi:10.1080/15294145.2001.10773355 · Cited by 35
Idiopathic Nightmares and Dream Disturbances Associated with Sleep–Wake Transitions
Nielsen, T., & Zadra, A. L. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6645-3.00097-9 · Cited by 40
Sleep Disturbances and Parkinson's Disease
Friedman, J. H., & Millman, R. P. (2008) · CNS Spectrums · doi:10.1017/s1092852900017272 · Cited by 32
“DREAMS IN PARKINSONS DISEASE Approximately 30% of patients treated with Ldopa develop either vivid dreams, night terrors, or nightmares.(26) These can be mistaken for hallucinations or confusional episodes by the family, for the patient may awaken believing that a vivid dream actually took place.”
BackgroundThe Interpretation of Dreams and the Neurosciences
Solms, M. (2001) · Psychoanalysis and History · doi:10.3366/pah.2001.3.1.79 · Cited by 38
Visual hallucinations in the elderly associated with the use of levodopa
Banerjee, A. K., Falkai, P., & Savidge, M. (1989) · Postgraduate Medical Journal · doi:10.1136/pgmj.65.764.358 · Cited by 31
Etiologies of insomnia in Parkinson's disease – Lessons from human studies and animal models
Mizrahi-Kliger, A. D., Feldmann, L. K., Kühn, A. A., & Bergman, H. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.113976 · Cited by 34
“Alterations in dream content are also relatively common during chronic dopaminergic treatment (Sharf et al., 1978), and were found to be strongly correlated with sleep fragmentation (Pappert et al., 1999).”
Excessive Daytime Sleepiness and Unintended Sleep Episodes Associated with Parkinson’s Disease
Salawu, F. K., & Olokoba, A. B. (2015) · Oman Medical Journal · doi:10.5001/omj.2015.02 · Cited by 29
Giménez-Roldán, S., Mateo, D., Navarro, E., & Ginés, M. M. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00024-9 · Cited by 27
Fox, K. C. R., Andrews‐Hanna, J. R., & Christoff, K. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.08.020 · Cited by 32
“… reports of increased vividness, duration, and emotionality of dreaming in Parkinson’s disease patients being treated with L-‐dopa, a precursor molecule of dopamine (as well as other neurotransmitters) (Moskovitz et al., 1978, Sharf et al., 1978, Solms, 2002).”
BackgroundTreatment of behavioural disturbances in Parkinson’s disease
Valldeoriola, F., Nobbe, F. A., & TOLOSA, E. S. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6846-2_15 · Cited by 25
Insomnia in neurological diseases
Aldrich, M. S. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90022-8 · Cited by 23
Collerton, D., & Perry, E. K. (2011) · Consciousness and Cognition · doi:10.1016/j.concog.2011.03.024 · Cited by 24
Malcolm‐Smith, S., Koopowitz, S., Pantelis, E., & Solms, M. (2011) · Consciousness and Cognition · doi:10.1016/j.concog.2011.11.004 · Cited by 25
Disturbed Dreaming in Medical Conditions
Nielsen, T. (2005) · Elsevier eBooks · doi:10.1016/b0-72-160797-7/50085-9 · Cited by 19
Foffani, G. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad442 · Cited by 20
“…factors, dopaminergic medication — primarily employed to improve motor functions — can both worsen psychotic (or psychotic-like) symptoms (114) and cause vivid dreams, night terrors, and nightmares (115, 116), which are also suggested to predict poor motor and cognitive evolution (117, 118).”
BackgroundBhidayasiri, R., Sringean, J., Rattanachaisit, W., & Truong, D. D. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.01.018 · Cited by 18
“The third report also suggested an association between sleep terrors and chronic levodopa therapy [60].”
Zea‐Sevilla, M. A., & Martínez‐Martín, P. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1217-z · Cited by 21
“Vivid dreaming is common in PD. Studies suggest that up to 30 % of patients on dopaminergic therapies develop vivid dreams (Sharf et al. 1978).”
BackgroundPsychosis in parkinsonism: an unorthodox approach
ONOFRJ, M. C., Carrozzino, D., D'Amico, A., Giacomo, R. D., Pizzi, S. D., Thomas, A., Onofrj, V., Taylor, J., & Bonanni, L. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s116116 · Cited by 18
“47,69,70,111,112 114 We postulate that the structure providing this narrative is probably the default mode network (DMN).”
Management of the behavioral aspects of Parkinson’s disease
Borek, L. L., Chou, K. L., & Friedman, J. H. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.6.711 · Cited by 18
Dream Anxiety Attacks (Nightmares)
Erman, M. K. (1987) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30541-0 · Cited by 18
Drug-Induced Psychosis in Parkinsonʼs Disease
Mendis, T., Barclay, C. L., & Mohr, E. (1996) · CNS Drugs · doi:10.2165/00023210-199605030-00003 · Cited by 15
Psychiatric Care in Parkinson’s Disease
Quelhas, R. (2013) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000428558.94329.6d · Cited by 14
Nonmotor Aspects of Parkinson's Disease
TOLOSA, E. S., Santamaría, J., Gaig, C., & Compta, Y. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00014-3 · Cited by 14
Treatment with Weak Electromagnetic Fields Restores Dream Recall in a Parkinsonian Patient
Sandyk, R. (1997) · International Journal of Neuroscience · doi:10.3109/00207459709000627 · Cited by 19
REM ocular activity in Parkinsonian patients chronically treated with levodopa
Lavie, P., Bental, E., Goshen, H., & Sharf, B. (1980) · Journal of Neural Transmission · doi:10.1007/bf01256640 · Cited by 12
Self-citationThe clinical associations of visual hallucinations
ONOFRJ, M. C., Thomas, A., Martinotti, G., Anzellotti, F., Giannantonio, M. D., Ciccocioppo, F., & Bonanni, L. (2014) · Wiley eBooks · doi:10.1002/9781118892794.ch5 · Cited by 15
Response to Commentaries by J. Allan Hobson and Edward F. Pace-Schott
Hobson, J. A., & Pace-Schott, E. F. (1999) · Neuropsychoanalysis · doi:10.1080/15294145.1999.10773262 · Cited by 16
Sleep Dysfunction in Movement Disorders: a Window to the Disease Biology
Standlee, J., & Malkani, R. G. (2022) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-022-01220-8 · Cited by 11
RBD: A Window into the Dreaming Process
Arnulf, I. (2018) · Springer eBooks · doi:10.1007/978-3-319-90152-7_17 · Cited by 18
Therapy of behavioral disorders in Parkinson's disease
Valldeoriola, F., & Molinuevo, J. L. (1999) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(99)80081-x · Cited by 10
Sleep disorders in Parkinson's disease: the nursing role
Crabb, L. (2001) · British Journal of Nursing · doi:10.12968/bjon.2001.10.1.5401 · Cited by 9
Disturbed Dreaming as a Factor in Medical Conditions
Nielsen, T. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6645-3.00098-0 · Cited by 10
Relationship between Dreaming and Memory Reconsolidation
Zhao, H., Li, D., & Li, X. (2018) · Brain Science Advances · doi:10.26599/bsa.2018.9050005 · Cited by 11
“As Solms argued [36], the level of dream recall can be modulated by dopamine agonists [37, 38] without concomitant modification of the duration and frequency of REM sleep.”
BackgroundSleep in Neurodegenerative Diseases
Iranzo, Á., & Santamaría, J. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2089-1_32 · Cited by 16
Trenkwalder, C., & Högl, B. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83015-6 · Cited by 9
Trenkwalder, C. (2005) · Elsevier eBooks · doi:10.1016/b0-72-160797-7/50074-4 · Cited by 9
Bugalho, P., Ladeira, F. F., Barbosa, R. P., Marto, J. P., Borbinha, C., Salavisa, M., da Conceição, L., Saraiva, M., Fernandes, M., & Meira, B. (2020) · Journal of Sleep Research · doi:10.1111/jsr.13163 · Cited by 7
Do Antihypertensives Make Tranylcypromine Safer?
Taylor, B. P., Quitkin, F. M., McGrath, P. J., & Stewart, J. W. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0519e · Cited by 7
Körner, Y., Meindorfner, C., Möller, J. C., Stiasny‐Kolster, K., Haja, D., Cassel, W., Oertel, W. H., & Kruger, H.-P. (2003) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1046/j.1439-054x.2003.03206.x · Cited by 7
Motor Functions and Dysfunctions of Sleep
Hening, W. A., Walters, A. S., & Chokroverty, S. (1994) · Elsevier eBooks · doi:10.1016/b978-0-7506-9002-7.50024-0 · Cited by 8
Drugs affecting autonomic functions or the extrapyramidal system
Karch, F. E. (1979) · Side effects of drugs annual · doi:10.1016/s0378-6080(79)80017-3 · Cited by 6
Neuropsychopharmacological Induction of (Lucid) Dreams: A Narrative Review
Oldoni, A. A., Bacchi, A. D., Mendes, F. R., Tiba, P. A., & Mota-Rolim, S. A. (2024) · Brain Sciences · doi:10.3390/brainsci14050426 · Cited by 10
Functions and Circuits of REM Sleep
Gazea, M., Rio‐Bermudez, C. D., Nissen, C., & Adamantidis, A. (2019) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-813743-7.00017-7 · Cited by 9
Sleep and Quality of Life in Parkinson’s Disease
Whitehead, D. L., Mitchell-Hay, R., Reddy, P., Muzerengi, S., & Chaudhuri, К. R. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-343-5_20 · Cited by 5
Neurobehavioral disorders in Parkinson's disease
Rabey, J. M. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83020-x · Cited by 4
Neuroleptics, Antihistamines and Antiparkinsonian Drugs: Effects on Sleep
Soldatos, C. R., & Dikeos, D. G. (1995) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57836-6_16 · Cited by 4
Mutti, C., Siclari, F., & Rosenzweig, I. (2024) · Journal of Sleep Research · doi:10.1111/jsr.14338 · Cited by 4
“Similarly, an increased availability of dopamine in the ventral striatum, either achieved through meditation, or through the iatrogenic effects of drugs such as L-dopa and pramipexole, has been associated with intense dream mentation and LD experiences (Pinter et al., 1999; Sharf et al., 1978).”
Metadata
- Authors
- Sharf, B., Moskovitz, C., Lupton, M. D., & Klawans, H. L.
- Affiliations
- Bnai Zion Medical Center (IL)
- Rush University Medical Center (US)
- Venue
- Journal of Neural Transmission
- Published
- 1978-06
- Volume
- 43
- Issue
- 2
- Pages
- 143-151
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2049922305
- Cited by
- 137
- References
- 29
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 5 · 2016: 3 · 2015: 5 · 2014: 2 · 2013: 4 · 2012: 2
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Parkinsonfonden
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Restless Legs Syndrome Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Keywords
- levodopa, levodopa/carbidopa, Parkinson's disease, vivid dreams, night terrors, nightmares, adverse drug reactions, treatment duration
- MeSH terms
- Adult, Aged, Carbidopa, Delusions, Dreams, Female, Hallucinations, Humans, Illusions, Levodopa, Long-Term Care, Male, Middle Aged, Parkinson Disease, Psychoses, Substance-Induced
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.